CRL
Charles River Laboratories International Inc.

913
Mkt Cap
$7.5B
Volume
755,080.00
52W High
$228.88
52W Low
$91.86
PE Ratio
-51.41
CRL Fundamentals
Price
$153.71
Prev Close
$151.97
Open
$155.50
50D MA
$191.06
Beta
1.44
Avg. Volume
1.39M
EPS (Annual)
-$2.91
P/B
2.36
Rev/Employee
$203,826.50
$12,557.80
Loading...
Loading...
News
all
press releases
National Bank of Canada FI Grows Stock Position in Charles River Laboratories International, Inc. $CRL
National Bank of Canada FI increased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 117.7% in the third quarter, according to the company in its most recent...
MarketBeat·13h ago
News Placeholder
More News
News Placeholder
Charles River Laboratories International, Inc. $CRL Holdings Reduced by Iron Triangle Partners LP
Iron Triangle Partners LP reduced its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 16.3% during the 3rd quarter, according to its most recent filing...
MarketBeat·2d ago
News Placeholder
Gotham Asset Management LLC Acquires 46,594 Shares of Charles River Laboratories International, Inc. $CRL
Gotham Asset Management LLC increased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 17.3% in the third quarter, according to its most recent disclosure...
MarketBeat·2d ago
News Placeholder
Earnest Partners LLC Raises Holdings in Charles River Laboratories International, Inc. $CRL
Earnest Partners LLC boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 0.8% in the 3rd quarter, according to the company in its most recent 13F filing...
MarketBeat·3d ago
News Placeholder
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Rating of "Moderate Buy" by Brokerages
Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) has been given an average rating of "Moderate Buy" by the sixteen ratings firms that are currently covering the firm...
MarketBeat·4d ago
News Placeholder
Zacks Research Issues Negative Outlook for CRL Earnings
Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Research analysts at Zacks Research lowered their Q1 2026 earnings per share (EPS) estimates for Charles River Laboratories...
MarketBeat·5d ago
News Placeholder
Connor Clark & Lunn Investment Management Ltd. Has $28.25 Million Stock Holdings in Charles River Laboratories International, Inc. $CRL
Connor Clark & Lunn Investment Management Ltd. decreased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 5.6% during the 3rd quarter, according to...
MarketBeat·5d ago
News Placeholder
Zacks Research Has Optimistic Outlook of CRL Q2 Earnings
Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Zacks Research lifted their Q2 2026 earnings per share estimates for Charles River Laboratories International in a report...
MarketBeat·6d ago
News Placeholder
Mackenzie Financial Corp Decreases Stock Holdings in Charles River Laboratories International, Inc. $CRL
Mackenzie Financial Corp lessened its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 0.7% during the 3rd quarter, according to its most recent disclosure with the...
MarketBeat·6d ago
News Placeholder
Charles River Laboratories International, Inc. $CRL Stock Position Lifted by Magnetar Financial LLC
Magnetar Financial LLC raised its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 1,379.8% during the 3rd quarter, according to the company in its most recent 13F...
MarketBeat·6d ago
<
1
2
...
>

Latest CRL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.